Pricing Log in Create free account
Friday 6 November 2026 Export LNTH’s income statement to Excel — free account

Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.

Revenue
+1.54%
EPS
−17.1%
Free cash flow
+7.71%
Total debt
+0.52%

Quarter to September 2026, against a year earlier

100.97 0.27 +0.27%
Market cap
$6.6B
P/E
24.3×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
4.25
Beneish M
−2.23
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Lantheus Holdings, Inc. (LNTH) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Lantheus Holdings, Inc. (LNTH) trades at a P/S ratio of 4.2×. Over the past ten years it has ranged from 0.0× (June 2015) to 9.1× (June 2022); the current reading is higher than 74% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.1× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.9× (27.81%)
FY2024 4.0× 21.46%
FY2023 3.3× (10.47%)
FY2022 3.7× (19.06%)
FY2021 4.6× 113.11%
FY2020 2.2× (6.54%)
FY2019 2.3× 32.11%
FY2018 1.7× (26.23%)
FY2017 2.4× 151.43%
FY2016 0.9× 233.75%

Quarterly newest first

Period P/S ratio Change
Sep 2026 4.2× (10.44%)
Jun 2026 4.6× 46.26%
Mar 2026 3.2× 9.00%
Dec 2025 2.9× 28.93%
43 more quarters

Against its own ten years

Low 0.0× High 9.1×
Ten-year median 2.8×
Current reading's percentile 73

P/S ratio against peers

Company P/S ratio
AMRX AMNEAL PHARMACEUTICALS, INC. compare 2.0×
HIMS Hims & Hers Health, Inc. compare 2.2×
SUPN Indivior Pharmaceuticals Inc. compare 2.4×
RDY Dr. Reddy's Laboratories Ltd compare 3.6×
LNTH Lantheus Holdings, Inc. 4.2×
ALKS Alkermes plc compare 4.3×
KNSA Kiniksa Pharmaceuticals International, plc compare 7.3×
LQDA Liquidia Corporation compare 8.8×
AMLX Amylyx Pharmaceuticals, Inc. compare 35.4×
Drug Manufacturers Specialty & Generic industry median 2.1×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on LNTH